24-minute watch
| Talk 3
of 5
EBMT: Debate: CAR T vs. BsAbs in R/R DLBCL
CAR T should be used as early as possible in the treatment of R/R DLBCL
Dr William Townsend
University College London Hospitals, London, UK
Prof. Catherine Thieblemont
Hospital Saint-Louis, Paris, France
Dr William Townsend, University College London Hospitals, London, UK, and Prof. Catherine Thieblemont, Hospital Saint-Louis, Paris, France, present evidence for and against the earlier use of CAR T-cell therapy vs. bispecific antibodies in the treatment of R/R DLBCL
